chr10-5102485-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_003739.6(AKR1C3):c.681G>T(p.Trp227Cys) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 28)
Failed GnomAD Quality Control
Consequence
AKR1C3
NM_003739.6 missense, splice_region
NM_003739.6 missense, splice_region
Scores
2
6
11
Splicing: ADA: 0.04147
2
Clinical Significance
Conservation
PhyloP100: 4.83
Genes affected
AKR1C3 (HGNC:386): (aldo-keto reductase family 1 member C3) This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM1
In a site Involved in ligand recognition and product release (size 0) in uniprot entity AK1C3_HUMAN
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AKR1C3 | NM_003739.6 | c.681G>T | p.Trp227Cys | missense_variant, splice_region_variant | 7/9 | ENST00000380554.5 | |
AKR1C3 | NM_001253908.2 | c.681G>T | p.Trp227Cys | missense_variant, splice_region_variant | 7/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AKR1C3 | ENST00000380554.5 | c.681G>T | p.Trp227Cys | missense_variant, splice_region_variant | 7/9 | 1 | NM_003739.6 | P4 | |
AKR1C3 | ENST00000439082.7 | c.681G>T | p.Trp227Cys | missense_variant, splice_region_variant | 7/9 | 5 | A1 | ||
AKR1C3 | ENST00000605149.5 | c.612G>T | p.Trp204Cys | missense_variant, splice_region_variant | 7/9 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 151480Hom.: 0 Cov.: 28 FAILED QC
GnomAD3 genomes
AF:
AC:
1
AN:
151480
Hom.:
Cov.:
28
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000660 AC: 1AN: 151480Hom.: 0 Cov.: 28 AF XY: 0.0000135 AC XY: 1AN XY: 73920
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
151480
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
73920
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.681G>T (p.W227C) alteration is located in exon 7 (coding exon 7) of the AKR1C3 gene. This alteration results from a G to T substitution at nucleotide position 681, causing the tryptophan (W) at amino acid position 227 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D
REVEL
Benign
Sift
Benign
.;.;D
Sift4G
Uncertain
D;D;D
Polyphen
0.40
.;.;B
Vest4
MutPred
Loss of catalytic residue at P230 (P = 0.0267);.;Loss of catalytic residue at P230 (P = 0.0267);
MVP
MPC
0.029
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at